Adan Ramos Rivera
About Adan Ramos Rivera
Adan Ramos Rivera is a Research Associate III at Sangamo Therapeutics, Inc., where he has worked since 2022. He previously held roles at the University of California, Santa Cruz, including Trades and Project Coordinator and Mailroom Clerk, and earned his Bachelor's degree in Molecular, Cell & Developmental Biology from the same institution.
Work at Sangamo Therapeutics
Adan Ramos Rivera has been employed at Sangamo Therapeutics, Inc. as a Research Associate III since 2022. In this role, he contributes to the company's research initiatives in the field of gene therapy and genomic medicine. His position involves conducting experiments, analyzing data, and collaborating with other researchers to advance the company's scientific objectives. Sangamo Therapeutics is known for its innovative approaches to treating genetic diseases.
Previous Experience at University of California, Santa Cruz
Adan held multiple positions at the University of California, Santa Cruz. He worked as a Trades and Project Coordinator from 2018 to 2019 for one year, where he managed various projects and coordinated trades activities. Prior to that, he served as a UCSC Mailroom Clerk from 2017 to 2018 for seven months, handling mail operations and supporting campus communication.
Education and Expertise
Adan Ramos Rivera earned a Bachelor's degree in Molecular, Cell & Developmental Biology from the University of California, Santa Cruz, completing his studies from 2014 to 2019. His academic background provides a strong foundation in biological sciences, which supports his current research role. He also graduated from Alliance Collins Family College-Ready High School, receiving his High School Diploma from 2010 to 2014.
Career Development
Adan's career path reflects a progression from academic studies to practical research experience. His roles at the University of California, Santa Cruz, including both the Trades and Project Coordinator and Mailroom Clerk positions, provided him with diverse skills that he applies in his current research associate role. His transition to Sangamo Therapeutics marks a significant step in his professional journey within the biotechnology sector.